Product Information
CHILDREN IBUPROFEN 100 MG/5 ML is a generic product labeled by Taro Pharmaceuticals U.S.A. Inc., priced at $0.0301 per ML under NDC 51672532108. Its NADAC has been published 70 times since Jun 4, 2025.
FDA first approved this application on Feb 22, 2021.
Strength
100 mg/5mL
Manufacturer
Taro Pharmaceuticals U.S.A. Inc.NDC
51672532108
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
IBUPROFENApproval Type
Generic (ANDA)
FDA Application
ANDA211666FDA Approved
2/22/2021
On Market Since
8/15/2024
Pharmacological Classes
Price Statistics
The NADAC for CHILDREN IBUPROFEN 100 MG/5 ML has been published 70 times since Jun 4, 2025, and over the history we have for it it has risen 4.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0301 per ML |
|---|---|
| All-time high | $0.0304 (Jun 10, 2026) |
| All-time low | $0.0289 (Jun 4, 2025) |
| 52-week high | $0.0304 |
| 52-week low | $0.0290 |
| Median price | $0.0297 |
| Average price | $0.0296 |
| Largest weekly change | +2.5% (May 20, 2026) |
| Weeks tracked | 70 |
| Tracking since | Jun 4, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Taro Pharmaceuticals U.S.A. Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
ibuprofen market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonsteroidal Anti-inflammatory Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CHILDREN IBUPROFEN 100 MG/5 ML?
The current National Average Drug Acquisition Cost (NADAC) for CHILDREN IBUPROFEN 100 MG/5 ML, manufactured by Taro Pharmaceuticals U.S.A. Inc., is $0.0301 per ML (NDC 51672532108), effective Sep 30, 2026.
How has the price of CHILDREN IBUPROFEN 100 MG/5 ML changed over time?
Over the history we have for it, the NADAC for CHILDREN IBUPROFEN 100 MG/5 ML has risen 4.2%. It has been tracked across 70 weekly CMS publications since Jun 4, 2025.
What are the highest and lowest recorded NADAC prices for CHILDREN IBUPROFEN 100 MG/5 ML?
Since Jun 4, 2025, the NADAC for CHILDREN IBUPROFEN 100 MG/5 ML has ranged from a low of $0.0289 (Jun 4, 2025) to a high of $0.0304 (Jun 10, 2026), with a median of $0.0297 per ML.
Are there cheaper alternatives to CHILDREN IBUPROFEN 100 MG/5 ML?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as CHILDREN IBUPROFEN 100 MG/5 ML in a comparable dosage form, but none are currently priced below it.
Who manufactures CHILDREN IBUPROFEN 100 MG/5 ML?
CHILDREN IBUPROFEN 100 MG/5 ML (NDC 51672532108) is labeled by Taro Pharmaceuticals U.S.A. Inc., and CMS classifies it as a generic product.